The ACR Research and Education Foundation (REF) has launched the Action Alliance network, a program that calls on rheumatologists, investigators, and health professionals to join the REF in asking patients and families to be a part of the conversation. The Action Alliance consists of two programs working together: From the Field Speakers Bureau and Patients and Families for Progress.
Where Will Kinase Inhibitors Fit into the RA Treatment Mix?
Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
Link between Autoimmunity and Environmental Exposure Needs Further Research
Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
A Patient’s Perspective on RA
I was diagnosed in April 2010, at 44 years old, with seropositive RA; the disease rapidly turned my life upside down.
Letter: RA Approval for IL-1Ra
Investors convinced the executives of Synergen that they needed to evaluate IL-1Ra for a disease with a more rapid outcome. RA studies were too slow to yield a quick profit. Thus, they picked sepsis syndrome.
ACR Honors Contributions to Rheumatology
Rheumatologists recognized for their work in the field
A Short History of Rheumatoid Arthritis Therapeutics
Or, why I chose to become a rheumatologist
Give Rheumatology Patients a Helping Hand
Nearly 10 million Americans suffer from carpal tunnel syndrome, a condition that disables a key nerve in the wrist resulting in numbness, tingling, weakness, and loss of function in the hands and wrist. These symptoms are similar to those of rheumatoid arthritis and other rheumatic conditions, and it is important that patients know the difference.
Opening a New Therapeutic Window for Rheumatoid Arthritis
New targets in rheumatoid arthritis: SYK, JAK, BTK
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 45
- Next Page »